Incretin‐based drugs and Retinopathy risk in Medicare Enrollees

First published 09/02/2017

Last updated 27/03/2024

EU PAS number:

EUPAS17776

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

RetinopathyProtocol 08FEB2017

English (883.98 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents